Rise in need for early diagnosis of chronic diseases, increase in demand for innovative diagnostic techniques, and surge in health awareness across the world are expected to propel the growth of the global digital PCR market
PORTLAND, Oregon, Feb. 20, 2019 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Digital PCR Market by Technology (Droplet Digital PCR (ddPCR) and BEAMing Digital PCR), Product Type (Digital PCR Equipment, Consumables & Reagents, and Software & Services), Application (Clinical Diagnostics, Research, and Forensics), and End User (Clinical Diagnostic Laboratories, Pharmaceuticals and Biotechnology Industries, and University and Government Organizations): Global Opportunity Analysis and Industry Forecast, 2018–2025". According to the report, the global digital PCR market was pegged at $318.22 million in 2017 and is projected to reach $1,206.46 million by 2025, growing with a CAGR of 18.0% through 2025.
Rise in demand for innovative diagnostic techniques and increase in health awareness have boosted the growth of the global digital PCR market. However, high cost of dPCR testing and limited expertise and accessibility in the emerging economies hinder the market growth. On the contrary, rise in need for early diagnosis of viral, genetic and infectious disease and surge in number of diagnostic centers across the globe are expected to create lucrative opportunities for the market players in the near future.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/654
Droplet digital PCR segment dominates the market
Droplet digital PCR segment held the largest share in 2017, contributing more than four-fifths of the total market. However, the BEAMing digital PCR segment is projected to manifest the fastest CAGR of 18.9% during the forecast period.
Software & services segment to manifest fastest growth by 2025
Software & services segment is projected to portray the fastest CAGR of 19.9% during the study period. However, consumables and reagents segment held the largest share in 2017, contributing more than half of the total market. The report also analyzes the segment of digital PCR systems.
Research segment to retain lion's share
The research segment contributed the largest share, holding nearly one-third of the market in 2017. However, the forensics segment is estimated to manifest the fastest CAGR of 18.8% during the forecast period. The report also studies the segment of clinical diagnostics.
Asia-Pacific region to portray fastest growth through 2025
Asia-Pacific region is projected to register the fastest CAGR of 17.7% during the forecast period, owing to increase in number of patients suffering from chronic diseases and improvement in healthcare facilities in the region. However, the North America region dominated the market in terms of revenue, contributing nearly half of the market, owing to presence of leading molecular diagnostics manufacturers and rise in number of patients using personalized medicines. The report also analyzes the other regions such as Europe and Latin America, Middle East and Africa (LAMEA).
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/654
Major market players
The report analyzes the major companies in the market including Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.), JN Medsys, Qiagen N.V. (Formulatrix, Inc.), Expedeon AG, Sysmex Corporation (Sysmex Inostics GmbH), Fluidigm Corporation, Merck KGaA, Stilla Technologies, and Thermo Fisher Scientific, Inc.
Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree
Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.
Pharma & biotech companies accounted for three-eighths share of the total market, and is estimated to grow with a high CAGR of 16.6% during the forecast period. The clinics segment accounted for the largest share in the global digital pathology market, as clinics deliver well-organized, documented, retrieved, and logistical pathological procedures.
The biomarkers and cancer segment dominates the market and the personalized medicine segment is expected to grow at a CAGR of 26.7%. DNA sequencing possesses the potential to recognize a broad spectrum of genetic differences and supplement the generation of potent biomarkers in medicine and disease diagnostics.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
SOURCE Allied Market Research